About BREXTEM
BREXTEM®, developed by South Korea–based biotech innovator Brexogen, is a cutting-edge exosome-infused aesthetic platform offering targeted skin and hair rejuvenation solutions. Launched in mid‑2025, the brand includes BREXTEM‑S for dermal revitalization—stimulating collagen and elastin production to reduce signsof skin aging—and BREXTEM‑H, formulated to support hair density by activating dermal papilla cells, reducing inflammation, and promoting follicle regeneration . Both products leverage Brexogen’s proprietary “Natural Biomacromolecule Cargo‑Controlled Exosome Platform,” featuring nano‑sized vesicles derived from human cord blood exosomes enriched with proteins, miRNAs, peptides, and growth factors.
BREXTEM - S | Exosome Skin Rejuvenation
BREXTEM-S is an advanced exosome-based
topical formulation engineered to support comprehensive skin rejuvenation. This
treatment combines human cord blood-induced pluripotent cell-derived
exosomes with powerful actives including niacinamide, propolis extract,
peptides, and adenosine to visibly enhance skin quality. Designed to target
wrinkles, acne scars, hyperpigmentation, and enlarged pores, BREXTEM-S promotes
collagen synthesis, improves skin elasticity, and refines texture. Its
multi-action formula supports regenerative pathways at the cellular level,
making it an ideal adjunct to microneedling, laser, and energy-based facial
treatments.
BREXTEM - H | Targeted Exosome Therapy for Hair Health
BREXTEM-H is a specialized exosome-based
treatment developed to enhance scalp vitality and support stronger, healthier
hair growth. Formulated with human cord blood-induced pluripotent
cell-derived exosomes, this therapy pairs regenerative exosomes with panthenol,
niacinamide, hydrolyzed keratin, biotin, and plant extracts to
improve scalp condition and hair fiber strength. Applied topically, it
stimulates hair follicle activity, promotes elasticity, and reinforces hair
resilience.
About Brexogen
Brexogen is a pioneering biotechnology company specializing in the research and development of advanced exosome-based therapies for both medical and aesthetic applications. The brand has established itself at the forefront of regenerative medicine through its proprietary Natural Biomacromolecule Cargo-Controlled Exosome Platform, designed to optimize exosome efficacy and therapeutic consistency.